Skip to main content
Top
Published in: Heart and Vessels 11/2020

01-11-2020 | Computed Tomography | Original Article

Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease

Authors: Kazuhiro Osawa, Akihiro Bessho, Soichiro Fuke, Shigeharu Moriyama, Asako Mizobuchi, Shunsuke Daido, Masamichi Tanaka, Akihisa Yumoto, Hironori Saito, Hiroshi Ito

Published in: Heart and Vessels | Issue 11/2020

Login to get access

Abstract

The coronary artery calcium data and reporting system (CAC-DRS) is a novel reporting system based on CAC severity. Lung cancer patients have a high risk of cardiovascular disease (CVD), for which CAC severity may provide additional prognostic information. Using non-gated, non-contrast computed tomography (CT), we evaluated the CAC-DRS for predicting CVD and all-cause death in patients with potentially curable resected lung cancer. We retrospectively studied 309 consecutive patients without a history of CVD (mean age 67.4 ± 8.2 years, 61% male) who underwent curative surgery for non-small-cell lung cancer between May 2012 and March 2019 at the Japanese Red Cross Okayama Hospital. Time to incidence of major adverse cardiac events (MACEs) (non-fatal myocardial infarction, non-fatal stroke and cardiovascular death) and all-cause death was analyzed using Fine and Gray and Cox regression models. The CAC-DRS score was assessed using standard chest CT without electrocardiogram gating. During 52-months’ median follow-up, 43 patients (13.4%) developed incident MACEs or died from any cause; the pathological cancer stages were Ia (n = 20), Ib (n = 8), IIa (n = 2), IIb (n = 2) and IIIa (n = 11). Patients had a graded increase in incidence of MACEs or all-cause death with increasing categories of CAC-DRS. The CAC-DRS score was significantly associated with incident MACEs or all-cause death after adjusting for confounding factors (hazard ratio 1.18; 95% confidence interval 1.10–1.25, p < 0.01). In conclusion, the CAC-DRS score on non-gated standard CT can predict incident MACEs and/or all-cause death in patients with potentially curable resected lung cancer. Lung cancer survivors with a greater CAC-DRS category may need more active management of cardiovascular risk factors.
Literature
1.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef
2.
go back to reference Moyer VA, Force USPST (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338PubMed Moyer VA, Force USPST (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160:330–338PubMed
3.
go back to reference Tanoue LT, Detterbeck FC (2009) New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther 9:413–423CrossRef Tanoue LT, Detterbeck FC (2009) New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther 9:413–423CrossRef
4.
go back to reference Artal Cortes A, Calera Urquizu L, Hernando Cubero J (2015) Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Transl Lung Cancer Res 4:191–197PubMedPubMedCentral Artal Cortes A, Calera Urquizu L, Hernando Cubero J (2015) Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Transl Lung Cancer Res 4:191–197PubMedPubMedCentral
5.
go back to reference Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, Douglas PS, Bhatia S, Chao C (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34:1122–1130CrossRef Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, Douglas PS, Bhatia S, Chao C (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34:1122–1130CrossRef
6.
go back to reference Zoller B, Ji J, Sundquist J, Sundquist K (2012) Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer 48:121–128CrossRef Zoller B, Ji J, Sundquist J, Sundquist K (2012) Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer 48:121–128CrossRef
7.
go back to reference Yuan M, Li QG (2018) Lung cancer and risk of cardiovascular disease: a meta-analysis of cohort studies. J Cardiothorac Vasc Anesth 32:e25–e27CrossRef Yuan M, Li QG (2018) Lung cancer and risk of cardiovascular disease: a meta-analysis of cohort studies. J Cardiothorac Vasc Anesth 32:e25–e27CrossRef
8.
go back to reference Schoormans D, Vissers PAJ, van Herk-Sukel MPP, Denollet J, Pedersen SS, Dalton SO, Rottmann N, van de Poll-Franse L (2018) Incidence of cardiovascular disease up to 13 year after cancer diagnosis: a matched cohort study among 32,757 cancer survivors. Cancer Med 7:4952–4963CrossRef Schoormans D, Vissers PAJ, van Herk-Sukel MPP, Denollet J, Pedersen SS, Dalton SO, Rottmann N, van de Poll-Franse L (2018) Incidence of cardiovascular disease up to 13 year after cancer diagnosis: a matched cohort study among 32,757 cancer survivors. Cancer Med 7:4952–4963CrossRef
9.
go back to reference Koene RJ, Prizment AE, Blaes A, Konety SH (2016) Shared risk factors in cardiovascular disease and cancer. Circulation 133:1104–1114CrossRef Koene RJ, Prizment AE, Blaes A, Konety SH (2016) Shared risk factors in cardiovascular disease and cancer. Circulation 133:1104–1114CrossRef
10.
go back to reference Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99:1232–1239CrossRef Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99:1232–1239CrossRef
11.
go back to reference Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW (1998) Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 21:105–113CrossRef Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW (1998) Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 21:105–113CrossRef
12.
go back to reference Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND (2018) Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J 39:2401–2408CrossRef Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND (2018) Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J 39:2401–2408CrossRef
13.
go back to reference Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM (2012) Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308:788–795CrossRef Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM (2012) Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308:788–795CrossRef
14.
go back to reference Blaha MJ, Budoff MJ, Tota-Maharaj R, Dardari ZA, Wong ND, Kronmal RA, Eng J, Post WS, Blumenthal RS, Nasir K (2016) Improving the CAC score by addition of regional measures of calcium distribution: multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging 9:1407–1416CrossRef Blaha MJ, Budoff MJ, Tota-Maharaj R, Dardari ZA, Wong ND, Kronmal RA, Eng J, Post WS, Blumenthal RS, Nasir K (2016) Improving the CAC score by addition of regional measures of calcium distribution: multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging 9:1407–1416CrossRef
15.
go back to reference Hecht HS, Blaha MJ, Kazerooni EA, Cury RC, Budoff M, Leipsic J, Shaw L (2018) CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the society of cardiovascular computed tomography (SCCT). J Cardiovasc Comput Tomogr 12:185–191CrossRef Hecht HS, Blaha MJ, Kazerooni EA, Cury RC, Budoff M, Leipsic J, Shaw L (2018) CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the society of cardiovascular computed tomography (SCCT). J Cardiovasc Comput Tomogr 12:185–191CrossRef
16.
go back to reference Dzaye O, Dudum R, Mirbolouk M, Orimoloye OA, Osei AD, Dardari ZA, Berman DS, Miedema MD, Shaw L, Rozanski A, Holdhoff M, Nasir K, Rumberger JA, Budoff MJ, Al-Mallah MH, Blankstein R, Blaha MJ (2019) Validation of the coronary artery calcium data and reporting system (CAC-DRS): dual importance of cac score and cac distribution from the coronary artery calcium (CAC) consortium. J Cardiovasc Comput Tomogr 14(1):12–17CrossRef Dzaye O, Dudum R, Mirbolouk M, Orimoloye OA, Osei AD, Dardari ZA, Berman DS, Miedema MD, Shaw L, Rozanski A, Holdhoff M, Nasir K, Rumberger JA, Budoff MJ, Al-Mallah MH, Blankstein R, Blaha MJ (2019) Validation of the coronary artery calcium data and reporting system (CAC-DRS): dual importance of cac score and cac distribution from the coronary artery calcium (CAC) consortium. J Cardiovasc Comput Tomogr 14(1):12–17CrossRef
17.
go back to reference International Expert C (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef International Expert C (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef
18.
go back to reference Osawa K, Trejo MEP, Nakanishi R, McClelland RL, Blaha MJ, Blankstein R, McEvoy JW, Ceponiene I, Stein JH, Sacco RL, Polak JF, Budoff MJ (2018) Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins. Eur J Prev Cardiol 25:1980–1987CrossRef Osawa K, Trejo MEP, Nakanishi R, McClelland RL, Blaha MJ, Blankstein R, McEvoy JW, Ceponiene I, Stein JH, Sacco RL, Polak JF, Budoff MJ (2018) Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins. Eur J Prev Cardiol 25:1980–1987CrossRef
19.
go back to reference Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF (2014) ACC/AHA 2013 guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2935–2959CrossRef Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF (2014) ACC/AHA 2013 guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2935–2959CrossRef
20.
go back to reference Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef
21.
go back to reference Tota-Maharaj R, Joshi PH, Budoff MJ, Whelton S, Zeb I, Rumberger J, Al-Mallah M, Blumenthal RS, Nasir K, Blaha MJ (2015) Usefulness of regional distribution of coronary artery calcium to improve the prediction of all-cause mortality. Am J Cardiol 115:1229–1234CrossRef Tota-Maharaj R, Joshi PH, Budoff MJ, Whelton S, Zeb I, Rumberger J, Al-Mallah M, Blumenthal RS, Nasir K, Blaha MJ (2015) Usefulness of regional distribution of coronary artery calcium to improve the prediction of all-cause mortality. Am J Cardiol 115:1229–1234CrossRef
22.
go back to reference Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50:e1–e157CrossRef Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50:e1–e157CrossRef
23.
go back to reference Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195CrossRef Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195CrossRef
24.
go back to reference Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e278S–e313SCrossRef Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e278S–e313SCrossRef
25.
go back to reference Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts H, Mak RH (2019) Cardiac radiation dose, cardiac disease, and mortality in patients with lung Cancer. J Am Coll Cardiol 73:2976–2987CrossRef Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts H, Mak RH (2019) Cardiac radiation dose, cardiac disease, and mortality in patients with lung Cancer. J Am Coll Cardiol 73:2976–2987CrossRef
26.
go back to reference Khan S, Chen CL, Brady MS, Parameswaran R, Moore R, Hassoun H, Carvajal RD (2012) Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma. J Clin Oncol 30:e163–164CrossRef Khan S, Chen CL, Brady MS, Parameswaran R, Moore R, Hassoun H, Carvajal RD (2012) Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma. J Clin Oncol 30:e163–164CrossRef
27.
go back to reference Ryberg M (2012) Recent advances in cardiotoxicity of anticancer therapies. Am Soc Clin Oncol Educ Book 2012:555–559CrossRef Ryberg M (2012) Recent advances in cardiotoxicity of anticancer therapies. Am Soc Clin Oncol Educ Book 2012:555–559CrossRef
28.
go back to reference Stocks T, Van Hemelrijck M, Manjer J, Bjorge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P (2012) Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension 59:802–810CrossRef Stocks T, Van Hemelrijck M, Manjer J, Bjorge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P (2012) Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension 59:802–810CrossRef
29.
go back to reference Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155–164CrossRef Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155–164CrossRef
30.
go back to reference Hecht HS, Cronin P, Blaha MJ, Budoff MJ, Kazerooni EA, Narula J, Yankelevitz D, Abbara S (2017) 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Thorac Imaging 32:W54–W66CrossRef Hecht HS, Cronin P, Blaha MJ, Budoff MJ, Kazerooni EA, Narula J, Yankelevitz D, Abbara S (2017) 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Thorac Imaging 32:W54–W66CrossRef
31.
go back to reference Hughes-Austin JM, Dominguez A 3rd, Allison MA, Wassel CL, Rifkin DE, Morgan CG, Daniels MR, Ikram U, Knox JB, Wright CM, Criqui MH, Ix JH (2016) Relationship of coronary calcium on standard chest CT scans with mortality. JACC Cardiovasc Imaging 9:152–159CrossRef Hughes-Austin JM, Dominguez A 3rd, Allison MA, Wassel CL, Rifkin DE, Morgan CG, Daniels MR, Ikram U, Knox JB, Wright CM, Criqui MH, Ix JH (2016) Relationship of coronary calcium on standard chest CT scans with mortality. JACC Cardiovasc Imaging 9:152–159CrossRef
32.
go back to reference Christensen JL, Sharma E, Gorvitovskaia AY, Watts JP Jr, Assali M, Neverson J, Wu WC, Choudhary G, Morrison AR (2019) Impact of slice thickness on the predictive value of lung cancer screening computed tomography in the evaluation of coronary artery calcification. J Am Heart Assoc 8:e010110CrossRef Christensen JL, Sharma E, Gorvitovskaia AY, Watts JP Jr, Assali M, Neverson J, Wu WC, Choudhary G, Morrison AR (2019) Impact of slice thickness on the predictive value of lung cancer screening computed tomography in the evaluation of coronary artery calcification. J Am Heart Assoc 8:e010110CrossRef
33.
go back to reference Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW (2015) Technology for innovation in radiation oncology. Int J Radiat Oncol Biol Phys 93:485–492CrossRef Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW (2015) Technology for innovation in radiation oncology. Int J Radiat Oncol Biol Phys 93:485–492CrossRef
34.
go back to reference Mousavi N, Nohria A (2013) Radiation-induced cardiovascular disease. Curr Treat Options Cardiovasc Med 15:507–517CrossRef Mousavi N, Nohria A (2013) Radiation-induced cardiovascular disease. Curr Treat Options Cardiovasc Med 15:507–517CrossRef
35.
go back to reference Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro CJ, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Ozguroglu M, Investigators P (2018) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 379:2342–2350CrossRef Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro CJ, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Ozguroglu M, Investigators P (2018) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 379:2342–2350CrossRef
36.
go back to reference Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhaufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crino L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373:1627–1639CrossRef Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhaufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crino L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373:1627–1639CrossRef
Metadata
Title
Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease
Authors
Kazuhiro Osawa
Akihiro Bessho
Soichiro Fuke
Shigeharu Moriyama
Asako Mizobuchi
Shunsuke Daido
Masamichi Tanaka
Akihisa Yumoto
Hironori Saito
Hiroshi Ito
Publication date
01-11-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 11/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01624-x

Other articles of this Issue 11/2020

Heart and Vessels 11/2020 Go to the issue